Encyclopedia of Autism Spectrum Disorders

2013 Edition
| Editors: Fred R. Volkmar

Noonan and Ras/Mapk Pathway Syndromes

  • Jacqueline A. NoonanEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-1698-3_355


Short Description or Definition

Noonan syndrome (NS) is a multiple malformation genetic disorder characterized by dysmorphic facies including hypertelorism, ptosis, low-set posteriorly rotated ears, short neck, and relative macrocephaly. Associated features include short stature, chest deformity, undescended testes, muscle hypotonia, frequent learning difficulties, and congenital heart disease most commonly valvular pulmonary stenosis. In 2001 (Tartaglia et al., 2001), a germline mutation in the PTPN11 gene in the Ras/MAPK (mitogen-activated protein kinase) signal transduction pathway was found to be a cause of nearly 50% of the cases of NS. Since then a number of other genes in the same pathway have been identified but in about 25% the causative gene for NS has yet to be identified.

Before NS was recognized as a distinct syndrome some females were misdiagnosed as having Turner syndrome and many males, given the diagnosis of male...

This is a preview of subscription content, log in to check access.

References and Readings

  1. Allanson, J. E., Hall, J. G., Hughes, H. E., Preus, M., & Witt, R. D. (1985). Noonan syndrome: The changing phenotype. American Journal of Medical Genetics, 21(3), 507–514.PubMedCrossRefGoogle Scholar
  2. Cesarini, L., Alfieri, A., Pantaleoni, F., Vasta, I., Cerutti, M., Petrangeli, V., et al. (2009). Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade. American Journal of Medical Genetics Part A, 149A(2), 165–170.CrossRefGoogle Scholar
  3. Ghaziuddin, M., Bolyard, B., & Alessi, N. (1994). Autistic disorder in noonan syndrome. Journal of Intellectual Disability Research, 38(Pt 1), 67–72.PubMedGoogle Scholar
  4. Kratz, C. P., Niemeyer, C. M., Castleberry, R. P., Cetin, M., Bergsträsser, E., Emanuel, P. D., et al. (2005). The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood, 106(6), 2183–2185.PubMedCrossRefGoogle Scholar
  5. Noonan, J. A. (1968). Hypertelorism with Turner phenotype. American Journal of Diseases of Children, 116(4), 373–380.PubMedGoogle Scholar
  6. Noonan, J. A. (2005a). Noonan syndrome. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of neurodevelopmental and genetic disorders in adults (pp. 308–319). New York: Guilford Press.Google Scholar
  7. Noonan, J. A. (2005b). Noonan syndrome and related disorders. Progress in Pediatric Cardiology, 20(2), 177–185.CrossRefGoogle Scholar
  8. Noonan, J. A., & Ehmke, D. A. (1963). Associated noncardiac malformations in children with congenital heart. Journal of Pediatrics, 31, 150–153.Google Scholar
  9. Opitz, J. M. (1985). The Noonan syndrome. American Journal of Medical Genetics, 21(3), 515–518.PubMedCrossRefGoogle Scholar
  10. Paul, R., Cohen, D. J., & Volkmar, F. R. (1983). Autistic behaviours in a boy with Noonan syndrome. Journal of Autism and Developmental Disorders, 13(4), 433–4.PubMedCrossRefGoogle Scholar
  11. Pierpont, E. I., Pierpont, M. E., Mendelshon, N. J., Roberts, A. E., Tworog-Dube, E., & Seidenberg, M. S. (2009). Genotype differences in cognitive functioning in Noonan syndrome. Genes, Brain and Behavior, 8(3), 275–282.CrossRefGoogle Scholar
  12. Pierpont, E. I., Weismer, S. E., Roberts, A. E., Tworog-Dube, E., Pierpont, M. E., Mendelshon, N. J., et al. (2010). The language phenotype of children and adolescents with Noonan syndrome. Journal of Speech, Language, and Hearing Research, 53, 917–932.PubMedCrossRefGoogle Scholar
  13. Romano, A. A., Allanson, J. E., Dahlgren, J., Gelb, B. D., Hall, B., Pierpont, M. E., et al. (2010). Noonan syndrome: Clinical features, diagnosis and management guidelines. Pediatrics, 126(4), 746–759.PubMedCrossRefGoogle Scholar
  14. Shaw, A. C., Kalidas, K., Crosby, A. H., Jeffery, S., & Patton, M. A. (2007). The natural history of Noonan syndrome: A long-term follow-up study. Archives of Disease in Childhood, 92(2), 128–132.PubMedCrossRefGoogle Scholar
  15. Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2 cause Noonan syndrome. Nature Genetics, 29(4), 465–468.PubMedCrossRefGoogle Scholar
  16. Tartaglia, M., Pennacchio, L. A., Zhao, C., Yadav, K. K., Fodale, V., Sarkozy, A., et al. (2007). Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nature Genetics, 39(1), 75–79.PubMedCrossRefGoogle Scholar
  17. Tidyman, W. E., & Rauen, K. A. (2008). Noonan, Costello and cardio-facio-cutaneous syndromes: Dysregulation of the Ras-MAPK pathway. Expert Reviews in Molecular Medicine, 10, e37.PubMedCrossRefGoogle Scholar
  18. Van der Burgt, I., Toonen, G., Roosenboom, N., Assman-Hulsmans, C., Gabreels, F., Otten, B., et al. (1999). Patterns of cognitive functioning in school-aged children with Noonan syndrome associated with variability in phenotypic expression. Journal of Pediatrics, 135(6), 707–713.PubMedCrossRefGoogle Scholar
  19. Verhoeven, W. M. A., Wingbermühle, E., Egger, J., Van Der Burgt, I., & Tuinier, S. (2007). Noonan syndrome: Psychological and psychiatric aspects. American Journal of Medical Genetics, 146A, 191–196.Google Scholar
  20. Watanabe, Y., Yano, S., Niihori, T., Aoki, Y., Matsubara, Y., Yoshino, M., et al. (2011). A familial case of LEOPARD syndrome associated with a high-functioning autism spectrum disorder. Brain and Development, 33(7), 576–579.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Kentucky, College of MedicineLexingtonUSA